← Back to Screener
ScreenerNewsCompareWatchlist
VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesNewsCompareWatchlist
AnalyzeValuationTotal ReturnDCA CalculatorInsider Activity
HomeStocksCGNXAnalysis
OverviewAnalysisPriceRevenueEarningsP/ERatiosDividendTargets
Analysis OverviewHoldUpdated May 1, 2026

CGNX logoCognex Corporation (CGNX) Stock Analysis

Wall Street verdict, consensus price target, and analyst rating breakdown — everything needed to frame the risk/reward at today's price.

Analyst consensus
Hold
Covering
31
analysts
14 bullish · 2 bearish · 31 covering CGNX
Strong Buy
1
Buy
13
Hold
15
Sell
2
Strong Sell
0
Consensus Target
$60
-3.3% vs today
Scenario Range
$48 – $204
Model bear to bull value window
Coverage
31
Published analyst ratings
Valuation Context
50.1x
Forward P/E · Market cap $10.4B

Decision Summary

Cognex Corporation (CGNX) is rated Hold by Wall Street. 14 of 31 analysts are bullish, with a consensus target of $60 versus a current price of $62.26. That implies -3.3% upside, while the model valuation range spans $48 to $204.

Note: Strong analyst support doesn't guarantee returns. At 50.1x forward earnings, much of the optimism may already be priced in. Use the scenario range to judge whether the upside justifies the risk.
Upside case
Street consensus points to -3.3% upside. The bull scenario stretches to +228.4% if CGNX re-rates higher.
Downside frame
The bear case maps to $48 — a -22.7% drop — if investor confidence compresses the multiple sharply.

CGNX price targets

Three scenarios for where CGNX stock could go

Current
~$62
Confidence
60 / 100
Updated
May 1, 2026
Where we are now
you are here · $62
Bear · $48
Base · $95
Bull · $204
Current · $62
Bear
$48
Base
$95
Bull
$204
Upside case

Bull case

$204+228.4%

CGNX would need investors to value it at roughly 165x earnings — about 114x more generous than today's 50x forward P/E. That requires meaningful multiple expansion on top of continued earnings growth.

Market caseClosest to today

Base case

$95+52.8%

At 77x on FY1 earnings, the base case reflects a reasonable but not stretched valuation. It prices in continued growth without assuming an exceptional setup.

Stress case

Bear case

$48-22.7%

If investor confidence fades or macro conditions deteriorate, a 11x multiple contraction could push CGNX down roughly 23% from where it trades now.

Not financial advice. Model confidence reflects internal scenario assumptions, not a guarantee of returns. Past performance does not predict future results.

CGNX logo

Cognex Corporation

CGNX · NASDAQTechnologyHardware, Equipment & PartsDecember year-end
Data as of May 1, 2026

Cognex Corporation is a machine vision technology company that provides systems and software to automate manufacturing and distribution processes through visual inspection and analysis. It generates revenue primarily from hardware sales of vision systems and sensors (~70%) and software licensing (~30%), serving industries like consumer electronics, automotive, and pharmaceuticals. The company's competitive advantage lies in its deep technical expertise, extensive patent portfolio, and established relationships with major manufacturers who rely on its reliable, high-precision vision solutions.

Market Cap
$10.4B
Revenue TTM
$994M
Net Income TTM
$114M
Net Margin
11.5%

CGNX Revenue and Earnings Performance

Quarterly beat-or-miss track record against analyst estimates, plus forward revenue and EPS outlook for the next two fiscal years.

EPS Beat Rate
92%Exceptional
12 quarters tracked
Revenue Beat Rate
83%Exceptional
vs consensus estimates
Avg EPS Surprise
+19.0%
above Street consensus
Beat / Miss Record
BeatMissLeft = EPS · Right = Revenue
Q2 2025
Q3 2025
Q4 2025
Q1 2026

Last 4 Quarters

EPS beats: 4 of 4
Q2 2025
EPS
$0.16/$0.13
+23.1%
Revenue
$216M/$249M
-13.2%
Q3 2025
EPS
$0.25/$0.23
+8.7%
Revenue
$249M/$248M
+0.4%
Q4 2025
EPS
$0.33/$0.27
+22.2%
Revenue
$277M/$239M
+15.9%
Q1 2026
EPS
$0.27/$0.22
+22.7%
Revenue
$252M/$239M
+5.6%
QuarterEPS (Actual / Est)EPS SurpriseRevenue (Actual / Est)Rev Surprise
Q2 2025$0.16/$0.13+23.1%$216M/$249M-13.2%
Q3 2025$0.25/$0.23+8.7%$249M/$248M+0.4%
Q4 2025$0.33/$0.27+22.2%$277M/$239M+15.9%
Q1 2026$0.27/$0.22+22.7%$252M/$239M+5.6%
FY1–FY2 Estimates
Revenue Outlook
FY1
$1.0B
+7.0% YoY
FY2
$1.1B
+6.1% YoY
EPS Outlook
FY1
$0.94
+45.0% YoY
FY2
$1.04
+10.1% YoY
Trailing FCF (TTM)$237M
FCF Margin: 23.8%
Next Earnings
May 6, 2026
Expected EPS
$0.25
Expected Revenue
$245M

CGNX beat EPS estimates in 4 of 4 tracked quarters. A perfect track record raises the bar for the upcoming report.

CGNX Revenue Breakdown by Segment

Product and geographic revenue mix from the latest annual disclosure, with year-over-year growth by segment.

Latest disclosure
FY 2025
Total disclosed revenue $994M

Product Mix

Latest annual revenue by segment or product family

Standard Product and Services
88.5%
+10.6% YoY

Tap, hover, or focus a slice to inspect segment detail.

SegmentYoYRevenueMix

Geographic Mix

Latest annual revenue by reported region

Americas
41.0%
+16.3% YoY

Tap, hover, or focus a slice to inspect segment detail.

SegmentYoYRevenueMix
Standard Product and Services is the largest disclosed segment at 88.5% of FY 2025 revenue, up 10.6% YoY.
Americas is the largest reported region at 41.0%, up 16.3% YoY.
See full revenue history

CGNX Valuation Snapshot

Current multiples compared to the S&P 500, the company's sector, and its own five-year average.

Relative Value Signal
Fairly Valued

Fair value est. $54 — implies -2.6% from today's price.

Premium to Fair Value
2.6%
above fair value
Deep DiscountFair ValueVery Expensive
vs S&P 500 Trailing P/E
CGNX
91.6x
vs
S&P 500
25.2x
+263% premium
vs Technology Trailing P/E
CGNX
91.6x
vs
Technology
27.5x
+233% premium
vs CGNX 5Y Avg P/E
Today
91.6x
vs
5Y Average
52.6x
+74% premium
Forward PE
50.1x
S&P 500
19.1x
+163%
Technology
21.7x
+131%
5Y Avg
—
—
Trailing PE
91.6x
S&P 500
25.2x
+263%
Technology
27.5x
+233%
5Y Avg
52.6x
+74%
PEG Ratio
—
S&P 500
1.75x
—
Technology
1.47x
—
5Y Avg
—
—
EV/EBITDA
52.8x
S&P 500
15.3x
+246%
Technology
17.4x
+204%
5Y Avg
38.0x
+39%
Price/FCF
43.9x
S&P 500
21.3x
+106%
Technology
19.8x
+122%
5Y Avg
47.2x
-7%
Price/Sales
10.5x
S&P 500
3.1x
+234%
Technology
2.4x
+333%
5Y Avg
8.6x
+21%
Dividend Yield
0.52%
S&P 500
1.88%
-72%
Technology
1.18%
-56%
5Y Avg
0.66%
-21%
MetricCGNXS&P 500· delta vs CGNXTechnology5Y Avg CGNX
Forward PE50.1x
19.1x+163%
21.7x+131%
—
Trailing PE91.6x
25.2x+263%
27.5x+233%
52.6x+74%
PEG Ratio—
1.75x
1.47x
—
EV/EBITDA52.8x
15.3x+246%
17.4x+204%
38.0x+39%
Price/FCF43.9x
21.3x+106%
19.8x+122%
47.2x
Price/Sales10.5x
3.1x+234%
2.4x+333%
8.6x+21%
Dividend Yield0.52%
1.88%
1.18%
0.66%
CGNX trades above S&P 500 benchmarks on 5 of 5 measured multiples — commands a broad premium across most valuation dimensions.

Forward P/E and PEG reflect analyst consensus estimates. Historical averages use trailing ratios where forward data is unavailable.S&P 500 and sector benchmarks both use trailing median P/E — similar readings indicate the broader index and sector are priced alike.

Open valuation tool

CGNX Financial Health

Verdict
Strong

CGNX generates $237M in free cash flow at a 23.8% margin — returns 2.0% of market cap to shareholders annually.

Cash Engine

Revenue, margins, and cash generation

Revenue (TTM)
Trailing-twelve-month sales base
$994M
Revenue Growth
TTM vs prior year
+8.7%
Gross Margin
Gross profit as a share of revenue
66.9%
Operating Margin
Operating income divided by revenue
16.3%
Net Margin
Net income divided by revenue
11.5%
EPS (TTM)
Diluted earnings per share, trailing twelve months
$0.68
Free Cash Flow (TTM)
Cash generation after capex
$237M
FCF Margin
FCF as share of revenue — the primary cash quality signal
23.8%

Capital Quality

ROIC, leverage, and debt serviceability

ROIC
Return on invested capital — primary competitive quality signal
9.0%
ROA
Return on assets, trailing twelve months
5.8%
Cash & Equivalents
Liquid assets on the balance sheet
$263M
Net Cash
Cash exceeds total debt — no net leverage
$186M
Debt Serviceability
Net debt as a multiple of annual free cash flow
Net cash ✓
ROE
Return on equity, trailing twelve months
7.7%

Shareholder Returns

How capital is returned to owners

Total shareholder yield
2.0%
Dividend
0.5%
Buyback
1.5%
Share Repurchases
Trailing buyback outflow — dollar magnitude of capital returned
$151M
Dividend / Share
Annualized trailing dividend per share
$0.32
Payout Ratio
Share of earnings distributed as dividends
47.7%
Shares Outstanding
Declining as buybacks retire shares
167M

All figures from the trailing twelve months. ROIC uses invested capital (equity + net debt).

Open full ratios page

CGNX Stock Risk Factors

Key factors that could pressure the stock price, compress the multiple, or weigh on future results.

AI analysis · updated April 29, 2026

01
High Risk

Competitive Landscape

The machine vision market is highly dynamic, characterized by rapid technological changes and increasing competition. Cognex's ability to maintain its market share and profitability hinges on its capacity to consistently introduce new products with enhanced functionality.

02
High Risk

Supply Chain Vulnerabilities

Cognex relies significantly on third-party contractors for manufacturing, which exposes it to supply chain vulnerabilities. Past incidents, such as a fire at a primary contract manufacturer's plant, underscore the risks associated with this reliance.

03
High Risk

Geopolitical Uncertainties

Cognex's operations and supply chain are vulnerable to geopolitical risks and trade uncertainties, which can disrupt business operations and impact financial performance.

04
Medium

Economic Volatility

The company's financial results are susceptible to seasonal and cyclical variations in customer purchasing patterns, as well as broader economic volatility, including interest rate hikes and inflation.

05
Medium

Profitability Concerns

Cognex has experienced shrinking adjusted operating margins and declining free cash flow margins over the past five years. The decreasing return on invested capital (ROIC) indicates potential challenges in generating profitable growth.

06
Medium

Sales Cycle Limitations

Cognex's short sales cycle limits visibility into future growth, making its growth trajectory vulnerable to market shifts or slowdowns.

07
Lower

Strategic Decisions

The recent sale of its Japan-focused trading business raises concerns about a smaller revenue base and potentially limited future growth opportunities.

08
Lower

Valuation Concerns

Some analysts consider Cognex's stock to be 'Modestly Overvalued' based on current valuation metrics, despite the company's strong financial health.

These are risk mechanisms, not predictions. The key question is which would force a cut to earnings estimates or a lower multiple than the market currently prices in.

Why CGNX Stock Could Outperform

Structural drivers behind the upside case and why the stock could outperform over the next 12 months.

AI analysis · updated April 29, 2026

01

AI and Machine Vision Leadership

Cognex is a leading provider of machine vision systems, software, sensors, and industrial barcode readers used in manufacturing and logistics automation. Their focus on AI is seen as a significant growth driver.

02

Revenue Growth and Stability

The company's AI-powered vision and broader market mix are expected to support revenue stability and pricing power. Recent Q4 earnings showed robust revenue, surpassing analyst forecasts, and Q1 projections are also higher than consensus estimates.

03

Margin Expansion

Efforts in cost control, operating leverage, and share buybacks are aimed at widening profit margins. The company has also demonstrated strong EBITDA growth and free cash flow generation.

04

Analyst Confidence

Cognex has a consensus rating of 'Moderate Buy' or 'Buy' from analysts, with a significant portion recommending 'Strong Buy.' The average price target suggests potential upside from the current stock price.

05

Financial Health and Dividend

Cognex has a healthy and sustainable dividend payout ratio, and has been increasing its dividend for 10 years.

A real bull case compounds — each driver matters most when it strengthens margins, supports capital returns, and keeps the company above the market's minimum growth bar simultaneously.

Price target page

CGNX Stock Price Performance

52-week range context and price returns across multiple time horizons. Dividend contribution is shown separately in the Capital Return section.

Current Price
$62.26
52W Range Position
98%
52-Week Range
Current price plotted between the 52-week low and high.
98% through range
52-Week Low
$27.61
+125.5% from the low
52-Week High
$63.01
-1.2% from the high
1 Month
+25.73%
3 Month
+46.94%
YTD
+68.6%
1 Year
+123.7%
3Y CAGR
+7.9%
5Y CAGR
-4.6%
10Y CAGR
+11.9%

Range context matters because valuation compression and earnings misses rarely hit from the same starting point. A stock already far below its high can still fall, but it is no longer carrying the same embedded optimism as one pressing a fresh peak.

Full price historyP/E history

CGNX vs Peers

Valuation, growth, and margin comparison against the closest publicly traded peers for this company.

Peer Set
Accurate peer set
Forward PE
50.1x
vs 41.2x median
+22% above peer median
Revenue Growth
+7.0%
vs +3.7% median
+92% above peer median
Net Margin
11.5%
vs 5.5% median
+110% above peer median
CompanyMkt CapFwd PERev GrwMarginRatingUpside
CGN
CGNX
Cognex Corporation
$10.4B50.1x+7.0%11.5%Hold-3.3%
KEY
KEYS
Keysight Technologies, Inc.
$62.9B41.2x+7.7%16.9%Buy-21.1%
COH
COHU
Cohu, Inc.
$2.3B93.2x+0.8%-11.5%Buy+0.3%
VIA
VIAV
Viavi Solutions Inc.
$12.3B57.3x+3.7%-4.0%Buy-39.2%
NOV
NOVT
Novanta Inc.
$5.0B39.0x+5.3%5.5%Buy+8.0%
KLI
KLIC
Kulicke and Soffa Industries, Inc.
$4.9B35.7x-3.9%7.2%Buy-33.4%

This peer comparison reflects companies with similar business models, product lines, or market positioning, supplemented by industry grouping when direct matches are limited.

CGNX Dividend and Capital Return

CGNX returns capital mainly through $151M/year in buybacks (1.5% buyback yield), with a modest 0.52% dividend — combining for 2.0% total shareholder yield.

Dividend SustainableFCF Well Covered
Total Shareholder Yield
2.0%
Dividend + buyback return per year
Buyback Yield
1.5%
Dividend Yield
0.52%
Payout Ratio
47.7%
How CGNX Splits Its Return
Div 0.52%
Buyback 1.5%
Dividend 0.52%Buybacks 1.5%

Dividend Profile

Yield, cadence, and growth quality

Dividend / Share
Trailing annualized cash dividend
$0.32
Growth Streak
Consecutive years of dividend increases
4Y
3Y Div CAGR
7.0%
5Y Div CAGR
-31.9%
Ex-Dividend Date
—
Payment Cadence
Quarterly
4 payments over the last 12 months

Buyback Engine

How much per-share support comes from repurchases

Repurchases (TTM)
Cash used for buybacks in the latest trailing period
$151M
Estimated Shares Retired
2M
Approx. Share Reduction
1.5%
Shares Outstanding
Current diluted share count from the screening snapshot
167M
At 1.5%/year, buybacks mechanically lift EPS even with flat earnings — each remaining share represents a slightly larger piece of the company.
YearDiv / ShareYoY GrwBB YieldTotal Yield
2026$0.09———
2025$0.33+6.6%2.5%3.4%
2024$0.30+7.0%1.1%1.9%
2023$0.29+7.5%1.1%1.8%
2022$0.27+8.2%2.5%3.0%
Full dividend history
FAQ

CGNX Investor Questions

Common questions answered from live analyst data and company financials.

7 questions
01

Is Cognex Corporation (CGNX) stock a buy or sell in 2026?

Cognex Corporation (CGNX) is rated Hold by Wall Street analysts as of 2026. Of 31 analysts covering the stock, 14 rate it Buy or Strong Buy, 15 rate it Hold, and 2 rate it Sell or Strong Sell. The consensus 12-month price target is $60, implying -3.3% from the current price of $62. The bear case scenario is $48 and the bull case is $204.

02

What is the CGNX stock price target for 2026?

The Wall Street consensus price target for CGNX is $60 based on 31 analyst estimates. The high-end target is $70 (+12.4% from today), and the low-end target is $50 (-19.7%). The base case model target is $95.

03

Is Cognex Corporation (CGNX) stock overvalued in 2026?

CGNX trades at 50.1x times forward earnings. The stock trades at a notable premium to the broad market, which is typical for businesses with strong free cash flow and above-average growth expectations. Based on current multiples versus the peer group, the relative model signals fairly valued. Whether the stock is over or undervalued ultimately depends on whether consensus earnings estimates are achievable.

04

What are the main risks for Cognex Corporation (CGNX) stock in 2026?

The primary risks for CGNX in 2026 are: (1) Competitive Landscape — The machine vision market is highly dynamic, characterized by rapid technological changes and increasing competition. (2) Supply Chain Vulnerabilities — Cognex relies significantly on third-party contractors for manufacturing, which exposes it to supply chain vulnerabilities. (3) Geopolitical Uncertainties — Cognex's operations and supply chain are vulnerable to geopolitical risks and trade uncertainties, which can disrupt business operations and impact financial performance. Each factor has the potential to pressure earnings or compress the stock's valuation multiple.

05

What is Cognex Corporation's revenue and earnings forecast?

Analyst consensus estimates CGNX will report consensus revenue of $1.0B (+7.0% year-over-year) and EPS of $0.94 (+45.0% year-over-year) for the upcoming fiscal year. The following year, analysts project $1.1B in revenue.

06

When does Cognex Corporation (CGNX) report its next earnings?

Cognex Corporation is expected to report its next earnings on approximately 2026-05-06. Consensus expects EPS of $0.25 and revenue of $245M. Over recent quarters, CGNX has beaten EPS estimates 92% of the time.

07

How much free cash flow does Cognex Corporation generate?

Cognex Corporation (CGNX) generated $237M in free cash flow over the trailing twelve months — a free cash flow margin of 23.8%. CGNX returns capital to shareholders through dividends (0.5% yield) and share repurchases ($151M TTM).

Continue Your Research

Cognex Corporation Stock Overview

Price chart, key metrics, financial statements, and peers

CGNX Valuation Tool

Is CGNX cheap or expensive right now?

Compare CGNX vs KEYS

Side-by-side financials, valuation, and ratings

Deep Dive Analysis

CGNX Price Target & Analyst RatingsCGNX Earnings HistoryCGNX Revenue HistoryCGNX Price HistoryCGNX P/E Ratio HistoryCGNX Dividend HistoryCGNX Financial Ratios

Related Analysis

Keysight Technologies, Inc. (KEYS) Stock AnalysisCohu, Inc. (COHU) Stock AnalysisViavi Solutions Inc. (VIAV) Stock AnalysisCompare CGNX vs COHUS&P 500 Mega Cap Technology Stocks
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screener
  • Themes
  • Market Valuation
  • Valuation
  • Compare
  • Total Return
  • DCA Calculator
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Follow @VCPScanner on X

Get weekly stock ideas — free

© 2026 VCP Scanner. All rights reserved.
About·Privacy Policy·Terms of Service
Not financial advice. Do your own research.